Lambert-eaton myasthenic syndrome

被引:7
|
作者
Weimer, Maria B. [1 ]
Wong, Joaquin [1 ]
机构
[1] Louisiana State Univ, Hlth Sci Ctr, Dept Neurol, New Orleans, LA 70118 USA
关键词
CELL LUNG-CANCER; NEUROMUSCULAR-TRANSMISSION; INTRAVENOUS IMMUNOGLOBULIN; AUTOIMMUNE DISORDERS; 3,4-DIAMINOPYRIDINE; DIAGNOSIS; THERAPY; PYRIDOSTIGMINE; GUANIDINE; DISEASES;
D O I
10.1007/s11940-009-0010-z
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Lambert Eaton myasthenic syndrome (LEMS) is a rare neuromuscular junction disease. Often, the signs and symptoms of LEMS are mistaken for myasthenia gravis and therefore the workup is misdirected. A physician must look for an occult malignancy when the diagnosis is made and then continue to search for a malignancy for at least 5 years after diagnosis. The diagnosis of LEMS can be confirmed with electrophysiologic studies or with serum calcium channel antibodies. In most patients with LEMS, 3,4-diaminopyridine will improve strength. In patients without malignancy, immunosuppressants do have a role in the treatment of LEMS. Patients and physicians must be aware that certain situations and drugs may exacerbate weakness.
引用
收藏
页码:77 / 84
页数:8
相关论文
共 50 条
  • [41] Lambert-Eaton Myasthenic syndrome associated with sarcoidosis
    García, FP
    Comabella, M
    Raguer, N
    Majó, J
    Montalban, X
    JOURNAL OF NEUROLOGY, 2005, 252 (09) : 1127 - 1128
  • [42] Endocrine function in Lambert-Eaton myasthenic syndrome
    Maddison, P
    Pinto, A
    Newsom-Davis, J
    ANNALS OF NEUROLOGY, 1999, 45 (03) : 414 - 415
  • [43] Lambert-Eaton Myasthenic Syndrome in Lung Cancer
    Wang, Yongbin
    Xu, Chuanguo
    Wang, Yu
    Feng, Feifei
    Wang, Hui
    Zhang, Ying
    Lin, Xiaojuan
    Xu, Bin
    CONTRAST MEDIA & MOLECULAR IMAGING, 2022, 2022
  • [44] VGCC antibodies and Lambert-Eaton Myasthenic Syndrome
    Verschuuren, Jan
    NEUROMUSCULAR DISORDERS, 2006, 16 : S103 - S103
  • [45] Autonomic dysfunction in Lambert-Eaton myasthenic syndrome
    Waterman, SA
    CLINICAL AUTONOMIC RESEARCH, 2001, 11 (03) : 145 - 154
  • [46] Enhanced ptosis in Lambert-Eaton myasthenic syndrome
    Brazis, PW
    JOURNAL OF NEURO-OPHTHALMOLOGY, 1997, 17 (03) : 202 - 203
  • [47] Lambert-Eaton myasthenic syndrome with ophthalmoparesis and pseudoblepharospasm
    Kanzato, N
    Motomura, M
    Suehara, M
    Arimura, K
    MUSCLE & NERVE, 1999, 22 (12) : 1727 - 1730
  • [48] LAMBERT-EATON MYASTHENIC SYNDROME WITH EXTERNAL OPHTHALMOPLEGIA
    BARKHAUS, PE
    RUBENFELD, M
    ANNALS OF NEUROLOGY, 1990, 28 (02) : 270 - 270
  • [49] Management/Treatment of Lambert-Eaton Myasthenic Syndrome
    Yohei Harada
    Jeffrey T. Guptill
    Current Treatment Options in Neurology, 2021, 23
  • [50] LAMBERT-EATON MYASTHENIC SYNDROME WITH LIMBIC ENCEPHALITIS
    Wymer, James
    Mckee, Mary Ann
    MUSCLE & NERVE, 2015, 52 : S131 - S131